(Q28196676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Giuseppe Borsani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PierFranco Spano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Marina Pizzi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

2

Flora Boroni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

4

Ilenia Sarnico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

3

Marina Benarese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

5

Valentina Ghisi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Laura Grazia Bresciani

6

object named as

Laura Grazia Bresciani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

7

Marina Ferrario

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neuroscience

19 January 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1711-1720

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Activation of nuclear factor-kappa B by beta-amyloid peptides and interferon-gamma in murine microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Shaping the nuclear action of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

NF-kB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Activation of c-Fos contributes to amyloid beta-peptide-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Production of beta-amyloid by primary human foetal mixed brain cell cultures and its modulation by exogenous soluble beta-amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

IKK mediates ischemia-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Hdmx and Mdm2 can repress transcription activation by p53 but not by p63.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Caspase cleavage of the amyloid precursor protein modulates amyloid β‐protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Microarray analysis of selected genes in neural stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Quantitative neuronal c-fos and c-jun expression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Extracellular amyloid formation and associated pathology in neural grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

NF-kappa B: a crucial transcription factor for glial and neuronal cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of kappa B kinase, and NF kappa B, do not reduce amyloid beta 42 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Identification of beta-amyloid-responsive genes by RNA differential display: early induction of a DNA damage-inducible gene, gadd45.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

PDZ domain-dependent suppression of NF-kappaB/p65-induced Abeta42 production by a neuron-specific X11-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Gene expression profile activated by the chemokine CCL5/RANTES in human neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.04722.X

10.1111/J.1460-9568.2006.04722.X

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623827%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017